ASX Announcement 20 November 2026 Resignation of Non-executive Director Genetic Signatures Limited (ASX:GSS) ("Genetic Signatures" or "the Company") advises that Dr Jenny Harry has tendered her resignation as a Non-Executive Director of the Company, effective 20 November 2026. In light of recent...
Board Changes and Final Director's Interest Notice
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Dr. Harry expressed gratitude for her time on the Board and believes it is the right moment to step aside due to recent developments. Chair Mike Aicher thanked Dr. Harry for her contributions over the past two years and wished her well for the future.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Genetic Signatures Ltd. on 6ix
Story so far
Earlier from Genetic Signatures
- BCAL Position on GSS-MAP Merger
- Withdrawal of Resolution 4 - Addendum to Notice of AGM
- MAP: Proposed Merger with GSS not proceeding
- End of Proposed Merger with Microba Life Sciences
- Trading Halt
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures